Top Vaccines companies in France by Net Cash Used Provided By Financing Activities

This ranking features the top 17 Vaccines companies in France ranked by Net Cash Used Provided By Financing Activities, totaling a Net Cash Used Provided By Financing Activities of USD -8.34 B, for February 06, 2025.
#
Name
Net Cash Used Provided By Financing Activities
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 370.08 M
Dec. 31, 2023 USD 5.91 -2.66%

France

2
USD 69.63 M
Dec. 31, 2023 USD 3.21 17.34%

France

3
USD 51.62 M
Dec. 31, 2023 USD 3.47 -1.52%

France

4
USD 32.10 M
Dec. 31, 2023 USD 2.43 0.68%

France

5
USD 27.54 M
March 31, 2024 USD 16.83 1.50%

France

6
USD 17.96 M
Dec. 31, 2023 USD 1.64 4.90%

France

7
USD 14.71 M
Dec. 31, 2023 USD 6.63 -0.22%

France

8
USD 13.79 M
Dec. 31, 2023 USD 1.39 1.77%

France

9
USD 6.77 M
Dec. 31, 2023 USD 4.22 -0.94%

France

10
USD 694.26 K
Dec. 31, 2023 USD 5.64 -2.27%

France

11
USD -1.86 M
Dec. 31, 2023 USD 3.53 -0.92%

France

12
USD -2.17 M
Dec. 31, 2023 USD 2.01 -0.78%

France

13
USD -2.17 M
Dec. 31, 2023 USD 2.58 -11.21%

France

14
USD -5.05 M
Dec. 31, 2023 USD 0.65 1.19%

France

15
USD -17.10 M
Dec. 31, 2023 USD 75.53 2.94%

France

16
USD -25.94 M
Dec. 31, 2023 USD 26.53 -0.92%

France

17
USD -8.89 B
Dec. 31, 2023 USD 107.78 1.15%

France

Frequently Asked Questions
  • Which Vaccines company in France has the highest Net Cash Used Provided By Financing Activities ?

    The Vaccines company in France with the highest Net Cash Used Provided By Financing Activities is ABIVAX SA (Paris Stock Exchange: ABVX.PA) at USD 370.08 M.

  • Which Vaccines company in France has the lowest Net Cash Used Provided By Financing Activities ?

    The Vaccines company in France with the lowest Net Cash Used Provided By Financing Activities is Sanofi (Paris Stock Exchange: SAN.PA) at USD -8.89 B.

SV Wall Street